Session

Liver & biliary (Posters)

A NOVEL ROLE FOR THE P53 FAMILY IN BACTERIAL TRANSLOCATION
A NOVEL ROLE FOR THE P53 FAMILY IN BACTERIAL TRANSLOCATION

NONINVASIVE BIOLOGICAL STEATOSIS AND FIBROSIS SCORES, USEFUL TOOLS FOR EVALUATING MAFLD (METABOLIC DYSFUNCTION ASSOCIATED FATTY LIVER DISEASE) PATIENTS
NONINVASIVE BIOLOGICAL STEATOSIS AND FIBROSIS SCORES, USEFUL TOOLS FOR EVALUATING MAFLD (METABOLIC DYSFUNCTION ASSOCIATED FATTY LIVER DISEASE) PATIENTS

ALCOHOL USE DISORDER AND ALCOHOL RELATED LIVER DISEASE: TIME FOR SCREENING?
ALCOHOL USE DISORDER AND ALCOHOL RELATED LIVER DISEASE: TIME FOR SCREENING?

TREATMENT OF HEPATITIS C WITH DIRECT ACTING ANTIVIRAL DRUGS CAN PROTECT AGAINST SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 INFECTION
TREATMENT OF HEPATITIS C WITH DIRECT ACTING ANTIVIRAL DRUGS CAN PROTECT AGAINST SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 INFECTION

ARE HEPATIC STEATOSIS PREDICTIVE SCORES STILL USEFUL TO PREDICT METABOLIC ASSOCIATED FATTY LIVER DISEASE (MAFLD) IN CROHN'S DISEASE PATIENTS?
ARE HEPATIC STEATOSIS PREDICTIVE SCORES STILL USEFUL TO PREDICT METABOLIC ASSOCIATED FATTY LIVER DISEASE (MAFLD) IN CROHN'S DISEASE PATIENTS?

ACCURACY OF MR IMAGING-ESTIMATED PROTON DENSITY FAT FRACTION FOR DETECTION AND CLASSIFICATION OF STEATOSIS IN NONALCOHOLIC FATTY LIVER DISEASE
ACCURACY OF MR IMAGING-ESTIMATED PROTON DENSITY FAT FRACTION FOR DETECTION AND CLASSIFICATION OF STEATOSIS IN NONALCOHOLIC FATTY LIVER DISEASE

VALIDATION OF PROGNOSTIC SCORES FOR PATIENTS WITH HEPATOCELLULAR CARCINOMA SUBMITTED TO TACE THERAPY
VALIDATION OF PROGNOSTIC SCORES FOR PATIENTS WITH HEPATOCELLULAR CARCINOMA SUBMITTED TO TACE THERAPY

PREDICTIVE FACTORS OF BACTERIAL INFECTION IN PATIENTS WITH LIVER CIRRHOSIS: EXPERIENCE OF THE HEPATO-GASTROENTEROLOGY DEPARTMENT CASABLANCA UNIVERSITY HOSPITAL
PREDICTIVE FACTORS OF BACTERIAL INFECTION IN PATIENTS WITH LIVER CIRRHOSIS: EXPERIENCE OF THE HEPATO-GASTROENTEROLOGY DEPARTMENT CASABLANCA UNIVERSITY HOSPITAL

HEPATIC AMYLOIDOSIS: PREVALENCE STUDY AND CLINICAL CHARACTERIZATION OF A RARE AND DEADLY DISEASE
HEPATIC AMYLOIDOSIS: PREVALENCE STUDY AND CLINICAL CHARACTERIZATION OF A RARE AND DEADLY DISEASE

DIAGNOSTIC ACCURACY OF ACOUSTIC RADIATION FORCE IMPULSE (ARFI) IMAGING AND TRANSIENT ELASTOGRAPHY FOR STAGING HEPATIC FIBROSIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)
DIAGNOSTIC ACCURACY OF ACOUSTIC RADIATION FORCE IMPULSE (ARFI) IMAGING AND TRANSIENT ELASTOGRAPHY FOR STAGING HEPATIC FIBROSIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)

PREDICTORS OF BLEEDING AFTER PROPHYLACTIC ENDOSCOPIC VARICEAL LIGATION
PREDICTORS OF BLEEDING AFTER PROPHYLACTIC ENDOSCOPIC VARICEAL LIGATION

AUTOIMMUNE HEPATITIS AND PRIMARY BILIARY CHOLANGITIS OVERLAP SYNDROME - WHAT ARE THE DIFFERENCES?
AUTOIMMUNE HEPATITIS AND PRIMARY BILIARY CHOLANGITIS OVERLAP SYNDROME - WHAT ARE THE DIFFERENCES?

EXTERNAL VALIDATION OF NEW FIB-4 THRESHOLDS FOR RULING IN CHRONIC HEPATITIS B RELATED FIBROSIS
EXTERNAL VALIDATION OF NEW FIB-4 THRESHOLDS FOR RULING IN CHRONIC HEPATITIS B RELATED FIBROSIS

THE ROLE OF VASCULARIZATION PARAMETERS QUANTIFICATION FOR THE ASSESSMENTS OF INCONCLUSIVE FOCAL LIVER LESIONS CHARACTERIZED BY CEUS
THE ROLE OF VASCULARIZATION PARAMETERS QUANTIFICATION FOR THE ASSESSMENTS OF INCONCLUSIVE FOCAL LIVER LESIONS CHARACTERIZED BY CEUS

VALIDATION OF NON-INVASIVE ALGORITHMS FOR DIAGNOSING ESOPHAGEAL VARICES IN PATIENTS WITH COMPENSATED ADVANCED CHRONIC LIVER DISEASE
VALIDATION OF NON-INVASIVE ALGORITHMS FOR DIAGNOSING ESOPHAGEAL VARICES IN PATIENTS WITH COMPENSATED ADVANCED CHRONIC LIVER DISEASE

ULTRASOUND VISCOELASTIC LIVER MEASUREMENTS AND FACTORS THAT INFLUENCE THEM
ULTRASOUND VISCOELASTIC LIVER MEASUREMENTS AND FACTORS THAT INFLUENCE THEM

OUTCOME OF LIVER TRANSPLANTATION FOR METASTATIC NEUROENDOCRINE TUMOURS
OUTCOME OF LIVER TRANSPLANTATION FOR METASTATIC NEUROENDOCRINE TUMOURS

ERCP IN BILROTH-II CASES. EXPERIENCE, TIPS AND TRICKS
ERCP IN BILROTH-II CASES. EXPERIENCE, TIPS AND TRICKS

ROLE OF ENDOSCOPIC ULTRASOUND IN EVALUATION OF BILE DUCT DILATATION: EXPERIENCE OF A TERTIARY CENTER
ROLE OF ENDOSCOPIC ULTRASOUND IN EVALUATION OF BILE DUCT DILATATION: EXPERIENCE OF A TERTIARY CENTER

ALCOHOL AS A RISK FACTOR FOR MORTALITY IN LIVER TRANSPLANT PATIENTS IN SWEDEN
ALCOHOL AS A RISK FACTOR FOR MORTALITY IN LIVER TRANSPLANT PATIENTS IN SWEDEN

Item 41 - 60 / 270
1 2
3
4 5 6 7 8 9 10 11 12 13 14